Atlas Trials

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Clinical trial NCT02274506 · WITHDRAWN

Trial details

NCT number
NCT02274506
Sponsor
M.D. Anderson Cancer Center
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Blood And Marrow TransplantationLeukemiaLymphoma
Start date
2014-10-20
Primary completion
2014-10-20
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.